Kathleen Telusma
Foot & Ankle Surgery · Gainesville, FLNPI 1225448061
Payments from drug & device makers
Across 80 payments — averaging $63.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CGG Medical Inc$3K
- Organogenesis Inc.$496
- Stryker$310
- Averitas Pharma Inc.$306
- Smith+Nephew$241
- Amgen$237
- plus $814 from 17 others
What the payments were for
- Food & beverage$2,40447%
- Education$2,69453%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CGG Medical Inc | 1 | $2,694 |
| Organogenesis Inc. | 16 | $496 |
| Stryker(2 entities) | 9 | $310 |
| Averitas Pharma Inc. | 8 | $306 |
| Smith+Nephew | 9 | $241 |
| Amgen | 9 | $237 |
| Medical Device Business Services, Inc. | 1 | $125 |
| Medtronic | 1 | $103 |
| Boston Scientific | 3 | $82 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
| Bioventus LLC | 3 | $57 |
| Integra Lifesciences Corporation | 3 | $57 |
| Stimwave Technologies Incorporated | 2 | $55 |
| Convatec Inc. | 2 | $52 |
| Arthrosurface Incorporated | 1 | $49 |
| Sebela Pharmaceuticals Inc. | 1 | $44 |
| Nevro Corp. | 1 | $29 |
| Misonix Inc | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $18 |
| Acell, Inc. | 1 | $17 |
| DJO, LLC | 1 | $15 |
| Acera Surgical, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,098 in reported general payments places this provider in the 60th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 12 | $1,565 |
| Gabapentin | 33 | $611 |
| Ketoconazole | 41 | $552 |
| Methylprednisolone | 28 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $182 |
| Silver Sulfadiazine | 16 | $81 |
| Naproxen | 15 | $72 |
| Meloxicam | 25 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Gainesville
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.